ArticleCardiovascular diabetology2015

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Stijn A Peeters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.